MRI catheterization in cardiopulmonary disease

Chest

Volumn 145, Issue 1, 2014, Pages 30-36

  Rogers, Toby ^a   Ratnayaka, Kanishka ^a,b   Lederman, Robert J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE STUDY; DEVICE SAFETY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART CATHETERIZATION; HEART OUTPUT; HEART RIGHT VENTRICLE PRESSURE; HEMODYNAMICS; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING CATHETERIZATION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; REVIEW;

CARDIAC CATHETERIZATION; CARDIAC IMAGING TECHNIQUES; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; HEART DEFECTS, CONGENITAL; HEART DISEASES; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; MAGNETIC RESONANCE IMAGING; PULMONARY HEART DISEASE;

EID: 84892648808     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1759     Document Type: Article

References (49)

1. McGoon M, Gutterman D, Steen V, et al American College of Chest Physicians. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidencebased clinical practice guidelines. Chest. 2004; 126 (1-suppl): 14S- 34S.
2. McLaughlin VV, Archer SL, Badesch DB, et al ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc, and the Pulmonary Hypertension Association. Circulation. 2009; 119 (16): 2250-2294.
3. Galiè N, Hoeper MM, Humbert M, et al ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009; 30 (20): 2493-2537.
4. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991; 115 (5): 343-349.
5. Cigarroa RG, Lange RA, Williams RH, Bedotto JB, Hillis LD. Underestimation of cardiac output by thermodilution in patients with tricuspid regurgitation. Am J Med. 1989; 86 (4): 417-420.
6. LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res. 1970; 4 (1): 23-30.
7. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984; 70 (4): 657-662.
8. Yared K, Noseworthy P, Weyman AE, McCabe E, Picard MH, Baggish AL. Pulmonary artery acceleration time provides an accurate estimate of systolic pulmonary arterial pressure during transthoracic echocardiography. J Am Soc Echocardiogr. 2011; 24 (6): 687-692.
9. Masuyama T, Kodama K, Kitabatake A, Sato H, Nanto S, Inoue M. Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure. Circulation. 1986; 74 (3): 484-492.
10. Pavlicek M, Wahl A, Rutz T, et al. Right ventricular systolic function assessment: rank of echocardiographic methods vs. cardiac magnetic resonance imaging. Eur J Echocardiogr. 2011; 12 (11): 871-880.
11. Tramarin R, Torbicki A, Marchandise B, Laaban JP, Morpurgo M. Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, Copenhagen. Eur Heart J. 1991; 12 (2): 103-111.
12. Hendel RC, Patel MR, Kramer CM, et al American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group; American College of Radiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American Society of Nuclear Cardiology; North American Soci ety for Cardiac Imaging; Society for Cardiovascular Angiog raphy and Interventions; Society of Interventional Radiology. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006; 48 (7): 1475-1497.
13. Voelkel NF, Quaife RA, Leinwand LA, et al National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006; 114(17): 1883-1891.
14. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001; 37 (1): 183-188.
15. Le Tourneau T, Deswarte G, Lamblin N, et al. Right ventricular systolic function in organic mitral regurgitation: impact of biventricular impairment. Circulation. 2013; 127 (15): 1597-1608.
16. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J. 2007; 28 (10): 1250-1257.
17. Barst RJ, Rubin LJ, Long WA, et al Primary Pulmonary Hypertension Study Group. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996; 334 (5): 296-301.
18. Gan CT, Lankhaar JW, Westerhof N, et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest. 2007; 132 (6): 1906-1912.
19. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 1995; 25 (5): 1143-1153.
20. Muthurangu V, Taylor A, Andriantsimiavona R, et al. Novel method of quantifying pulmonary vascular resistance by use of simultaneous invasive pressure monitoring and phase-contrast magnetic resonance flow. Circulation. 2004; 110 (7): 826-834.
21. Muthurangu V, Atkinson D, Sermesant M, et al. Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization. Am J Physiol Heart Circ Physiol. 2005; 289 (3): H1301 - H1306.
22. Kuehne T, Yilmaz S, Steendijk P, et al. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: In vivo validation and clinical application in patients with pulmonary hypertension. Circulation. 2004; 110 (14): 2010-2016.
23. Gagliardi MG, Bevilacqua M, Di Renzi P, Picardo S, Passariello R, Marcelletti C. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol. 1991; 68 (10): 1089-1091.
24. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004; 52 (1): 141-146.
25. Ugander M, Oki AJ, Hsu LY, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J. 2012; 33 (10): 1268-1278.
26. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004; 109 (20): 2411-2416.
27. Bürk J, Blanke P, Stankovic Z, et al. Evaluation of 3D blood flow patterns and wall shear stress in the normal and dilated thoracic aorta using flow-sensitive 4D CMR. J Cardiovasc Magn Reson. 2012; 14: 84.
28. Lorenz R, Bock J, Barker AJ, et al. 4D flow magnetic resonance imaging in bicuspid aortic valve disease demonstrates altered distribution of aortic blood flow helicity [published online ahead of print May 28, 2013]. Magn Reson Med. doi:10.1002/mrm.24802.
29. Razavi R, Hill DL, Keevil SF, et al. Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet. 2003; 362 (9399): 1877-1882.
30. Ratnayaka K, Faranesh AZ, Hansen MS, et al. Real-time MRI-guided right heart catheterization in adults using passive catheters. Eur Heart J. 2013; 34 (5): 380-389.
31. Pasqua AD, Barcudi S, Leonardi B, Clemente D, Colajacomo M, Sanders SP. Comparison of contrast and noncontrast magnetic resonance angiography for quantitative analysis of thoracic arteries in young patients with congenital heart defects. Ann Pediatr Cardiol. 2011; 4 (1): 36-40.
32. Hartung MP, Grist TM, François CJ. Magnetic resonance angiography: current status and future directions. J Cardiovasc Magn Reson. 2011; 13: 19.
33. Warnes CA, Williams RG, Bashore TM, et al American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease); American Society of Echocardiography; Heart Rhythm Society; International Society for Adult Congenital Heart Disease; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Manage- ment of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Soci ety for Adult Congenital Heart Disease, Society for Cardio vascular Angiography and Interventions, and Soci ety of Thoracic Surgeons. J Am Coll Cardiol. 2008; 52 (23): e143 - e263.
34. Beels L, Bacher K, De Wolf D, Werbrouck J, Thierens H. gamma-H2AX foci as a biomarker for patient X-ray exposure in pediatric cardiac catheterization: are we underestimating radiation risks? Circulation. 2009; 120 (19): 1903-1909.
35. Ait-Ali L, Andreassi MG, Foffa I, Spadoni I, Vano E, Picano E. Cumulative patient effective dose and acute radiation-induced chromosomal DNA damage in children with congenital heart disease. Heart. 2010; 96 (4): 269-274.
36. Sodickson A, Baeyens PF, Andriole KP, et al. Recurrent CT, cumulative radiation exposure, and associated radiationinduced cancer risks from CT of adults. Radiology. 2009; 251 (1): 175-184.
37. Ohno Y, Hatabu H, Murase K, et al. Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion. AJR Am J Roentgenol. 2007; 188 (1): 48-56.
38. Nishimura RA, Carabello BA. Hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation. 2012; 125 (17): 2138-2150.
39. Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol. 2010; 56 (11): 855-863.
40. Fujimoto N, Borlaug BA, Lewis GD, et al. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation. 2013; 127 (1): 55-62.
41. Blumberg FC, Arzt M, Lange T, Schroll S, Pfeifer M, Wensel R. Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension. Eur J Heart Fail. 2013; 15 (7): 771-775.
42. Sonmez M, Saikus CE, Bell JA, et al. MRI active guidewire with an embedded temperature probe and providing a distinct tip signal to enhance clinical safety. J Cardiovasc Magn Reson. 2012; 14: 38.
43. Bell JA, Saikus CE, Ratnayaka K, et al. Active delivery cable tuned to device deployment state: enhanced visibility of nitinol occluders during preclinical interventional MRI. J Magn Reson Imaging. 2012; 36 (4): 972-978.
44. Saikus CE, Ratnayaka K, Barbash IM, et al. MRI-guided vascular access with an active visualization needle. J Magn Reson Imaging. 2011; 34 (5): 1159-1166.
45. Halabi M, Ratnayaka K, Faranesh AZ, et al. Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility. J Cardiovasc Magn Reson. 2013; 15: 10.
46. Ratnayaka K, Saikus CE, Faranesh AZ, et al. Closed-chest transthoracic magnetic resonance imaging-guided ventricular septal defect closure in swine. JACC Cardiovasc Interv. 2011; 4 (12): 1326-1334.
47. Raval AN, Karmarkar PV, Guttman MA, et al. Real-time MRI guided atrial septal puncture and balloon septostomy in swine. Catheter Cardiovasc Interv. 2006; 67 (4): 637-643.
48. Raval AN, Telep JD, Guttman MA, et al. Real-time magnetic resonance imaging-guided stenting of aortic coarctation with commercially available catheter devices in swine. Circulation. 2005; 112 (5): 699-706.
49. Halabi M, Faranesh AZ, Schenke WH, et al. Real-time cardiovascular magnetic resonance subxiphoid pericardial access and pericardiocentesis using off-the-shelf devices in swine. J Cardiovasc Magn Reson. 2013; 15: 61.